Computational Discovery of Picomolar Qo Site Inhibitors of Cytochrome bc1 Complex
Authors:
- 12 June 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 134 (27) , 11168-11176
Abstract
A critical challenge to the fragment-based drug discovery (FBDD) is its low-throughput nature due to the necessity of biophysical method-based fragment screening. Herein, a method of pharmacophore-linked fragment virtual screening (PFVS) was successfully developed. Its application yielded the first picomolar-range Qo site inhibitors of the cytochrome bc1 complex, an important membrane protein for drug and fungicide discovery. Compared with the original hit compound 4 (Ki = 881.80 nM, porcine bc1), the most potent compound 4f displayed 20 507-fold improved binding affinity (Ki = 43.00 pM). Compound 4f was proved to be a noncompetitive inhibitor with respect to the substrate cytochrome c, but a competitive inhibitor with respect to the substrate ubiquinol. Additionally, we determined the crystal structure of compound 4e (Ki = 83.00 pM) bound to the chicken bc1 at 2.70 Å resolution, providing a molecular basis for understanding its ultrapotency. To our knowledge, this study is the first application of the FBDD method in the discovery of picomolar inhibitors of a membrane protein. This work demonstrates that the novel PFVS approach is a high-throughput drug discovery method, independent of biophysical screening techniques.Keywords
This publication has 41 references indexed in Scilit:
- Subnanomolar Inhibitor of Cytochrome bc1 Complex Designed by Optimizing Interaction with Conformationally Flexible ResiduesJournal of the American Chemical Society, 2009
- AutoGrow: A Novel Algorithm for Protein Inhibitor DesignChemical Biology & Drug Design, 2009
- Modeling the Catalysis of Anti-Cocaine Catalytic Antibody: Competing Reaction Pathways and Free Energy BarriersJournal of the American Chemical Society, 2008
- Comparison of multiple Amber force fields and development of improved protein backbone parametersProteins: Structure, Function, and Bioinformatics, 2006
- Binding of the Respiratory Chain Inhibitor Antimycin to the Mitochondrial bc1 Complex: A New Crystal Structure Reveals an Altered Intramolecular Hydrogen-bonding PatternJournal of Molecular Biology, 2005
- Crystallographic Studies of Quinol Oxidation Site Inhibitors: A Modified Classification of Inhibitors for the Cytochrome bc 1 ComplexJournal of Molecular Biology, 2004
- Modeling the Qo site of crop pathogens in Saccharomyces cerevisiae cytochrome bEuropean Journal of Biochemistry, 2004
- The CCP4 suite: programs for protein crystallographyActa Crystallographica Section D Structural Biology, 1994
- The Protonmotive Q Cycle in Mitochondria and BacteriaCritical Reviews in Biochemistry and Molecular Biology, 1994
- Application of RESP charges to calculate conformational energies, hydrogen bond energies, and free energies of solvationJournal of the American Chemical Society, 1993